Suppr超能文献

草药和膳食补充剂引起的肝损伤:近期文献综述要点

Herbal and dietary supplement induced liver injury: Highlights from the recent literature.

作者信息

Woo Stephanie M, Davis William D, Aggarwal Soorya, Clinton Joseph W, Kiparizoska Sara, Lewis James H

机构信息

Department of Internal Medicine, MedStar Georgetown University Hospital, Washington, DC 20007, United States.

Department of Gastroenterology, MedStar Georgetown University Hospital, Washington, DC 20007, United States.

出版信息

World J Hepatol. 2021 Sep 27;13(9):1019-1041. doi: 10.4254/wjh.v13.i9.1019.

Abstract

Herbal-induced liver injury (HILI) is an important and increasingly concerning cause of liver toxicity, and this study presents recent updates to the literature. An extensive literature review was conducted encompassing September 2019 through March 2021. Studies with clinically significant findings were analyzed and included in this review. We emphasized those studies that provided a causality assessment methodology, such as Roussel Uclaf Causality Assessment Method scores. Our review includes reports of individual herbals, including , green tea extract, kratom as well as classes such as performance enhancing supplements, Traditional Chinese medicine, Ayurvedic medicine and herbal contamination. Newly described herbals include ashwagandha, boldo, skyfruit, and 'Thermo gun'. Several studies discussing data from national registries, including the United States Drug-Induced Liver Injury (DILI) Network, Spanish DILI Registry, and Latin American DILI Network were incorporated. There has also been a continued interest in hepatoprotection, with promising use of herbals to counter hepatotoxicity from anti-tubercular medications. We also elucidated the current legal conversation surrounding use of herbals by presenting updates from the Federal Drug Administration. The highlights of the literature over the past year indicate interest in HILI that will continue as the supplement industry in the United States grows.

摘要

草药性肝损伤(HILI)是肝脏毒性的一个重要且日益受到关注的原因,本研究介绍了该领域文献的最新进展。我们进行了一项广泛的文献综述,涵盖2019年9月至2021年3月。分析了具有临床重要发现的研究并纳入本综述。我们重点关注了那些提供因果关系评估方法的研究,如罗塞尔·优克福因果关系评估法评分。我们的综述包括关于单一草药的报告,如绿茶提取物、 kratom,以及诸如增强性能的补充剂、中药、阿育吠陀医学和草药污染等类别。新描述的草药包括南非醉茄、波尔多叶、天果和“热枪”。纳入了几项讨论来自国家登记处数据的研究,包括美国药物性肝损伤(DILI)网络、西班牙DILI登记处和拉丁美洲DILI网络。人们对肝脏保护也一直很感兴趣,草药有望用于对抗抗结核药物的肝毒性。我们还通过介绍美国食品药品监督管理局的最新情况,阐明了目前围绕草药使用的法律讨论。过去一年文献的亮点表明,随着美国补充剂行业的发展,对HILI的关注将持续下去。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d0/8473494/e3a6510548a6/WJH-13-1019-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验